Skip to content
Unrated Drug recall · FDA · Published September 16, 2013

Osmotica Recalls Venlafaxine 225mg Due to Dissolution Failure

Osmotica Pharmaceutical Corp recalls specific lots of Venlafaxine 225mg extended-release tablets due to failed dissolution specifications. Check your bottle NDC and lot numbers.

🇺🇸 FDA recall #D-1067-2013DrugOsmotica ›
Take action

Contact the company

Recalling firmOsmotica Pharmaceutical Corp895 Sawyer Rd · Marietta, GA 30062
✎ GovInfoNow plain-language explainer

What happened, in plain English

Osmotica Pharmaceutical Corp is recalling Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, because they failed a dissolution specification test at the 12-hour time point for products with an 18-month shelf life. The recall affects 57,857 bottles distributed nationwide. The record does not specify what consumers should do with these medications or if there is a remedy available. Read more at govinfonow.com/recall/46598-osmotica-pharmaceutical-corp-recalls-venlafaxine-venlafaxine-hydrochloride-extended-release-tablets.

Source Summary by GovInfoNow · govinfonow.com/recall/46598-osmotica-pharmaceutical-corp-recalls-venlafaxine-venlafaxine-hydrochloride-extended-release-tablets · Updated October 13, 2026 · FDA enforcement record: FDA #D-1067-2013

Cite this page

“Osmotica Recalls Venlafaxine 225mg Due to Dissolution Failure.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46598-osmotica-pharmaceutical-corp-recalls-venlafaxine-venlafaxine-hydrochloride-extended-release-tablets. Based on FDA recall #D-1067-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1067-2013%22&limit=1).

Why it’s dangerous

The recalled tablets failed to meet dissolution specifications, meaning the drug may not release properly from the extended-release formulation over time. This could result in the medication not working effectively or releasing too quickly, potentially affecting treatment outcomes. The record does not describe specific injuries but notes the failure occurs at the 12-hour mark for products nearing their 18-month shelf life.

Who’s affected

Patients prescribed Venlafaxine 225 mg extended-release tablets who purchased the affected lots between the manufacturing date and the expiration date of January 2014. Individuals with these specific bottles are at risk of receiving medication that may not dissolve as intended.

How to tell if you have this one

Check your bottle for NDC numbers 0131-3268-32 (30-count) or 0131-3268-46 (90-count). Verify the lot numbers: a) 58975, 58976, 58977, 65165; or b) 58973, 58974, 65131. All affected lots have an expiration date of 01/14.

  • Brand
    Osmotica
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your Venlafaxine bottle matches the NDC and lot numbers listed in the recall record.

  2. Contact Your Pharmacist

    Speak with your pharmacist or healthcare provider to determine how to proceed, as the specific remedy is not stated in the record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 8 months after the firm started it.

1. Firm started the recall: Sep 16, 201312. FDA classified it Class III: Sep 27, 201323. Published in FDA’s Enforcement Report: Oct 9, 201334. FDA terminated the recall: May 9, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1067-2013 (September 16, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1067-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA